newsfilter
← Latest News
Business Wire·

Rallybio Announces Collaboration to Advance Therapeutic Solutions for Pregnant Individuals at Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)

- Rallybio to Receive Funding for FNAIT Awareness Initiative and Equity Investment from Johnson & Johnson - Rallybio Corporation (NASDAQ:RLYB), a clinical-stage biotechnology company committed to identifying and